ArticleNeuro-oncology advances

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases.

Iris M Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.